Biofrontera AG announced the launch of its independent sales force in the UK to drive the expansion of Ameluz for photodynamic therapy (PDT). Biofrontera's dedicated sales team will be led by Alexander Richardson, who joins Biofrontera from Galderma. Mr. Richardson was Head of Galderma's Prescription Business Unit for more than 10 years, managing sales that totaled 28 million. Prior to Galderma, Mr. Richardson worked for Sanofi-Aventis in the UK in Marketing and Medical Education roles.